| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | WO2002102978A3 Human growth hormone antagonists |
| 04/10/2003 | US20030069294 Alpha-substituted carboxylic acid derivatives |
| 04/10/2003 | US20030069292 Central nervous system disorders; anticonvulsants |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069234 CXCR3 antagonists |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1017681B1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 04/09/2003 | EP0946165B1 Integrin antagonists |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105106C Naphthol derivatives and rpocess for preparation thereof |
| 04/08/2003 | US6545155 Fused heteroaromatic glucokinase activators |
| 04/08/2003 | US6545015 Useful in therapy of bacterial infections, fungal infections |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/03/2003 | WO2003027130A2 Transition metal complexes for preparing olefin oligomers |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003026587A2 Compounds useful for treating hepatitus c virus |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents |
| 04/03/2003 | US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1297819A2 Composition for dyeing keratinous fibres comprising a cationic azo dye |
| 04/02/2003 | EP1296945A1 Sulfonamide derivatives |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP0998463B1 Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates |
| 04/02/2003 | EP0951485B1 Method of controlling polymer molecular weight and structure |
| 04/02/2003 | EP0936218B1 Benzimidazole derivatives |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541499 Benzimidazole derivatives; e.g., 5-hydroxy-1-(3-methoxy-4-((1,2,4-triazol-1-yl)-methyl)benzyl) -2-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-benzimidazole |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 03/27/2003 | WO2003024937A1 Benzimidazolylalkoxyaryl alkanoic acid derivatives and their use as antihyperglycemics |
| 03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 03/27/2003 | WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024395A2 Linked biaryl compounds |
| 03/27/2003 | WO2002060879A3 Bacterial gyrase inhibitors and uses thereof |
| 03/27/2003 | WO2002042262A3 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
| 03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/26/2003 | EP1294823A1 Double-spiro organic compounds and electroluminescent devices |
| 03/26/2003 | EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 03/26/2003 | EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/26/2003 | EP0763026B1 Gastrin and cck antagonists |
| 03/26/2003 | EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/26/2003 | CA2405024A1 Composition for the dyeing of human keratinic fibres which contains a specific monoazoic and monocationic dye |
| 03/25/2003 | WO2003000254A1 Fused cyclic compounds and medicinal use thereof |
| 03/25/2003 | US6537712 Dry development systems |
| 03/25/2003 | CA2423800A1 Fused cyclic compounds and medicinal use thereof |
| 03/20/2003 | WO2002051810A3 Integrin receptor ligands |
| 03/20/2003 | WO2002030886A3 Heterocyclic angiogenesis inhibitors |
| 03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 03/20/2003 | US20030055087 As analgesic |
| 03/20/2003 | US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives |
| 03/20/2003 | US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children |
| 03/20/2003 | US20030055054 CXCR3 antagonists |
| 03/20/2003 | US20030055037 Benzimidazole and indole derivatives as CRF receptor modulators |
| 03/19/2003 | EP1292594A1 Quinazoline derivatives for the treatment of tumours |
| 03/19/2003 | EP1292581A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 03/19/2003 | EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/18/2003 | US6534535 Inhibitors of factor Xa |
| 03/18/2003 | US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection |
| 03/13/2003 | WO2003020698A2 Protein tyrosine kinase inhibitors |
| 03/13/2003 | WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 03/13/2003 | WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 03/13/2003 | US20030050475 Contacting a 5 or 6-methyl quinoxaline with a halogenating agent in the presence of radical initiator in solvent (mono,di,tri fluoro or chlorobenzenes or a,trichloro or fluorotoluene to form 5 or 6- halomethylquinoxaline |
| 03/13/2003 | US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 03/13/2003 | CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients |
| 03/12/2003 | EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) |
| 03/12/2003 | EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1401631A Bis (amino carbonylnaphthol) derivs. |
| 03/12/2003 | CN1102925C Bis-(aminocarbonylnaphthol) derivatives |
| 03/11/2003 | US6531610 Intermediate acylating carbonate |
| 03/06/2003 | WO2003018029A1 Anti-bacterial agents based upon oxoanion binding |
| 03/06/2003 | WO2002098901A3 Peptide deformylase inhibitors |
| 03/06/2003 | CA2455504A1 Anti-bacterial agents based upon oxoanion binding |
| 03/05/2003 | EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 03/05/2003 | EP0969819B1 New crystalline form of omeprazole |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/05/2003 | CN1102595C Penems and their derivatives |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 02/27/2003 | WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002060374A3 Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
| 02/27/2003 | CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/25/2003 | US6525220 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |